Thyroid hormones and antioxidant systems: Focus on oxidative stress in cardiovascular and pulmonary diseases

International Journal of Molecular Sciences

Volumn 14, Issue 12, 2013, Pages 23893-23909

  Mancini, Antonio ^a   Raimondo, Sebastiano ^a   Di Segni, Chantal ^a   Persano, Mariasara ^a   Gadotti, Giovanni ^a   Silvestrini, Andrea ^a   Festa, Roberto ^b   Tiano, Luca ^b   Pontecorvi, Alfredo ^a   Meucci, Elisabetta ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

"Low T3" Syndrome; Coenzyme Q10; Oxidative stress; Thyroid hormones; Total antioxidant capacity

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROXINE; THYROXINE BINDING GLOBULIN; UBIDECARENONE; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; UBIQUINONE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; HEART MUSCLE CELL; HEART MUSCLE OXYGEN CONSUMPTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; LUNG DISEASE; LUNG FUNCTION; NONHUMAN; OSTEOPOROSIS; OXIDATION; OXIDATIVE STRESS; REVIEW; ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; METABOLISM; PATHOLOGY;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTHYROIDISM; LUNG DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THYROID HORMONES; UBIQUINONE;

EID: 84890214654     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141223893     Document Type: Review

References (113)

1. Kalyanaraman B., Teaching the basic of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox. Biol. 2013, 1, 244-257.
2. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine; Oxford University Press: Oxford, UK, 2007.
3. Chen, K.; Keaney, J.F., Jr. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr. Atheroscler. Rep. 2012, 14, 476-483.
4. Mancini, A.; Festa, R.; Raimondo, S.; Pontecorvi, A.; Littarru, G.P. Hormonal influence on Coenzyme(Q10) levels in blood plasma. Int. J. Mol. Sci. 2011, 12, 9216-9225.
5. Mancini, A., Festa R., di Donna V., Leone E., Littarru G.P., Silvestrini A., Meucci E., Pontecorvi A. Hormones and antioxidant syste: Role of pituitary and pituita-dependent axes. J. Endocrinol. Invest. 2010, 33, 422-433.
6. Littarru, G.P. Energy and Defence; CESI: Rome, Italy, 1994.
7. Crane F.L., Biochemical Functions of Coenzyme Q10. J. Am. Coll. Nutr. 2001, 20, 591-598.
8. Kaltschmidt, B.; Sparna, T.; Kaltschmidt, C. ActivatioN F-κB by reactive oxygen intermediates in the nervous system. Antioxid. Redox. Signal. 1999, 1, 129-144.
9. Chattopadhyay, S.; Zaidi, G.; Das, K.; Chainy, G.N.B. Effects of hypothyroidism inducb y 6-n-propylthiouracil and its reversal by T3 on rat heart superoxide dismutase, catalase and lipid peroxidation. Indian J. Exp. Biol. 2003, 41, 846-849.
10. De Groot L. N th-yroidal illness syndrome is a manifestation of hypotha-pituitary dysfunction, and in view of current evidence, shoud be treated with appropriate replacement therapy. Crit. Care Clin. 2006, 22, 57-86.
11. Fernandez, V.; Barrientos, X.; Kipreos, K.; Valanzuela, A.; Videla, L.A. Superoxide radical generation, NADPH oxidase activity and cytochrome-4P50 content of rat liver microsomal fractions in a experimental hyperthryoid tea: Relation to lipid peroxidation. Endocrinology 1985, 117, 496-501.
12. Asayama, K.; Dobashi, K.; Hayashibe, H.; Megata, Y.; Kato, K. Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat:A possible mechanism of injury to heart and skeletal muscle in hypothyroidism. Endocrinology 1987, 121, 2112-2118.
13. Swaroop, A., Ramasarma T. Heatexposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Biochem. J. 1985, 226, 403-408.
14. Resch, U.; Helsel, G.; Tatzber, F.; Sinzinger, H. Antioxidant status in thyroid dysfunction. Clin. Chem. Lab. Med. 2002, 40, 1132-1134.
15. Asayama, K.; Kato, K. Oxidative muscular injury and its relevance to hyperthyroidism. Free Radic. Biol. Med. 1990, 8, 293-303.
16. Dobrzynska, M.M.; Baumgartner, A.; Anderson, D. Antioxidants modulate thyroid hormonea nd noradrenaline-induced DNA damage in human sperm. Mutagenesis 2004, 19, 325-330.
17. Venditti, P., di Meo, S. Thyroid hormone-induced oxidative stress. Cell. Mol. Life Sci. 2006, 63, 414-434.
18. Hoch, F.L. Lipids and thyroid hormones. Prog. Lipid Res. 1988, 27, 199-270.
19. Mancini A., Giacchi E., Raimondo di S., Seni C., Silvestrini, A.; Meucci E. Hypothyroidism, Oxidative Stress and Reproduction. In Hypothyroidism-Influences and Treatments; Springer, D., Ed.; InTech: Rijeka, Croatia, 2012; pp. 117-134.
20. Venditti, P.; Balestrieri, M.; di Meo, S.; de Leo, T. Effect of thyroid state on lipid peroxidation, antioxidant defenses and susceptibility to oxidative stress in rat tissues. J. Endocrinol. 1997, 155, 151-157.
21. Huh, K.; Kwon, T.H.; Kim, J.S.; Park, J.M. Role of the hepatic xanthine oxidase in thyroid dysfunction: Effect of thyroid hormones in oxidative stress in rat liver. Arch. Pharm. Res. 1998, 21, 236-249.
22. Venditti, P.; Daniele, M.C.; Masullo di Meo, S. Antioxid stensitive triiodothyronine effects on characteristics of rat liver mitochondrial population. Cell. Physiol. Biochem. 1999, 9, 38-52.
23. Choudhury, S.; Chainy, G.B.N.; Mishro, M.M. Experimentally induced hypo-and hyper-thyroidism influence on the antioxidant defense system in adult rat testis. Andrologia 2003, 35, 131-140.
24. Araujo, A.S.R.; Schenkel, P.; Enzveiler, A.T.; Fernandes, T.R.G.; Partata, W.A.; Llesuy, S.; Ribeiro, M.F.M.; Khaper, N.; Singal, P.K.; Bellò-Klein, A. The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. J. Mol. Endocrinol. 2008, 41, 423-430.
25. Araujo, A.S.R.; Diniz, G.P.; Seibel, F.E.R.; Branchini, G.; Ribeiro, M.F.M.; Brum, I.S.; Khaper, N.; Barret-Chaves, M.L.M.; Bellò-Klein, A. Reactive oxygen and nitrogen species balance in the determination of thyroid horm induced cardiac hypertrophy mediated by renin-angiotensin system. Mol. Cell. Endocrinol. 2011, 333, 78-84.
26. Moreno, J.M.; Gomez, I.R.; Wangensteen, R.; Osuna, A.; Bueno, P.; Vargas, F. Cardiac and renal antioxidant enzymes and effect of tempol in hyperthyroid A ma.t sJ. Physiol. Endocrinol. Metab. 2005, 289, E776-E783.
27. Moreno, J.M.; Gomez, I.R.; Wangensteen, R.; uerraŗez M.; Luna, J.D.D.; Garcia-Estan, J.; Vargas, F. Tempol improves renal hemodynamics and pressure natriuresis in hyperthyroid rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294, R867-R873.
28. Ademoglu, E.; Gokkusu, C.; Yarman, S.; Azizlerli, H. The effect of methimazole on oxida st and antioxidants system in patients with hyperthyroidism. Pharmacol. Res. 1998, 3, 93-96.
29. Bianchi, G.; Solaroli, E.; Zaccheroni, V.; Grossi, G.; Bargossi, A.M.; Melchionda N. Oxidative stress and a-oxidant metabolites in patients with hyperro dism: Effect of treatment. Horm. Metab. Res. 1999, 31, 620-624.
30. Mancini, A.; de Marinis, L.; Calabrò, F.; Fiumara, C.; Goglia, A.; Littarru, Physiopathological Relevance of Coenzyme Q10 in Thyroid Disorders: CoQ10Concentrations in Normal and Diseased Human Thyroid Tissue. Biomedical and Clinical Aspects of Coenzyme. Folkers, K., Littarru, G.P., Yamagami, Eds.,; Elsevier: Amsterdam, The Netherlands, 1991; pp. 441-448.
31. Mancini, A.; de Marinis, L.; Calabrò, F.; Sciuto, R.; Oradei, A.; Lippa, S.; Sandric, S.; Littarru, G.P.; Barbarino, AE valuation of metabolic status in amiodar ineduced thyroid disorders: Plasma coenzyme Q10 determination. J. Endocrinol. Invest. 1989, 12, 511-516.
32. Mancini, A.; Corbo, G.M.; Gaballo, A.; Valente, S. Gigliotti P., Cimino V., de Marinis L., Principi F., Littarru G.P. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. Biofactors 2005, 25, 201-204.
33. Horrum, M.A.; Tobin, R.B.; Ecklund, R.E. Thyroxine-induced changes in rat liver mitochondrial ubiquinone. Biochem. Biophys. Res. Commun. 1986, 138, 381-386.
34. Baskol, G.; Atmaca, H.; Tanriverdi, F.; Baskol, M.; Kocer, D.; Bayram, F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp. Clin. Endocrinol. Diab. 2007, 115, 522-526.
35. Torun, A.N.; Kulaksizoglu, S.; Kulaksizoglu, M.; Pamuk, B.O.; Isbilen, E.; Tutuncu, N.B. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin. Endocrinol. 2009, 70, 469-474.
36. Coria, M.J.; Pastràn, A.I.; Gimenez, M.S.Serum oxidative stress parameters of women with hypothyroidism. Acta Biomed. 2009, 80, 135-139.
37. Erdamar, H.; Demirici, H.; Yaman, H.; Erbil, M.K.; Yakar, T.; Sancak, B. Elbeg, S Biberoglu G., Yetkin I. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin. Chem. Lab. Med. 2008, 46, 1004-1010.
38. Azizi, F.; Raiszadeh, F.; Solati, Se rum paraoxonase 1 activity is decreased in thyroid dysfunction. J. Endocrinol. Invest. 2003, 26, 703-109.
39. Santi A.; Duarte M.M.; Moresco R.N.; Menezes C.; Bagatini Schetinger M.R.; Loro V.L. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin. Chem. Lab. Med. 2010, 48, 1635-1639.
40. Nanda, N.; Bobby, Z.; Hamide, A.; Koner, B.C.; Sridar M. Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 2007, 56, 1350-1355.
41. Kebapcilar, L.; Akinci, B.; Bayraktar, F.; Comlekci, A.; Solak, A.; Demir, T.; Yener, S.; Kume T.; Yesi l S. Plasma thiobarbituric a-credactive substance levels in subclinical hypothyroidism. Med. Princ. Pract. 2007, 16, 432-436.
42. Mancini, A.; Leone, E.; Silvestrini, A.; Festa R., di Donna V.; de Marinis L.; Pontecorvi A.; Littarru G.P.; Meucci E. Evaluation of antioxidant systems in pituit-aydrenal axis diseases. Pituitary 2010, 13, 138-145.
43. Mancini, A.; Leone, E.; Festa, R.; Grande, G.; Silvestrini Ade Marinis, L.; Pontecorvi A.; Maira G.; Littarru G.P.; Meucci E. Effects of testosterone on antioxidant systems in male secondary hypogonadism. J. Androl. 2008, 29, 622-629.
44. Ohye, H.; Sugawara, M. Dual oxidase, hydrogen peroxide and thyroid diseases.Exp. Biol. Med. 2010, 235, 424-433.
45. Varela, V.; Rivolta, C.M.; Esperante, S.A.; GrPape dieck, L.; Chiesa, A.; Targovnik, H.M. Three mutations (p.Q36H, p.G418fsX482, and g.IVS19 > C) in the dual oxidase 2 gene responsible for congenital goiter and iodide organification defe Clin. Chem. 2006, 52, 182-191.
46. Ohye, H.; Fukata, S.; Hishinuma, A.; Kudo, T.; Nishihara, E.; Ito, M.; Kubota, S.; Amino, N.; Ieiri, T.; Kuma K.,et al. A novel homozygous missense mutation of the dual oxidase 2 (DUOX2) gene in an adult patient with large goiter. Thyroid 2008, 18, 561-566.
47. Weyemi, U.; Caillou, B.; Talbot, M.; Ameziane-El-Hassani, R.; Lacroix, L.; Lagent-Chevallier, O.; Al Ghuzlan, A.; Roos, D.; Bidart, J.M.; Virion, et.al. Intracellular expression of ROS generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.Endocr. Relat. Cancer 2010, 17, 27-37.
48. Sharma, R.; Traore, K.; Trush, M.A.; Rose, N.R.; Burek, C.L. Intracellular adhesion molecu-1 up-regulation on thyrocytes by iodine of noonb-ese diabetic H2(h4) mice is reactive oxygen species-dependent. Clin. Exper. Immunol. 2008, 152, 13-20.
49. Hennig, B.; Toborek, M.; McClain, C.J. Energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J. Am. Coll. Nutr. 2001, 20, 97-105.
50. Mertens, A.; Verhamme, P.; Bielicki, J.K.; Phillips, C.; Quarck, R.; Verreth, W.; Stengel, D.; Ninio, E.; Navab, M.; Mackness, B et al. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increate macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003, 107, 1640-1646.
51. Pereira, B.; Costa Rosa, F.B.P.; Safi D.A.; Becjhr E.J.H.; Curi R. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J. Endocrinol. 1994, 140, 73-77.
52. Paller, M.S.; Sikora, J.J. Hypothyroidism protects against free radical damage in ischemic acute renail failure. Kidney Int. 1986, 29, 1162-1166.
53. Reaven, P.D.; Ferguson, E.; Navab, M.; Powell, F.L. Susceptibility of human LDL oxidative modification: Effects of variation in β-carotene concentration and oxygen tension. Arterioscler. Thromb. 1994, 14, 1162-1169.
54. Bonanome, A.; Pagnan, A.; Biffanti, S.; Opportuno, A.; Sorgato, F.; Dorella, M.; Maiorino, M.; Ursini, F. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler.Thromb. 1992, 12, 529-533.
55. Aggarwal, N.T.; Makielski, J.C. Redox control of cardiac excitability. Antioxid.Redox Signal. 2013, 18, 432-468.
56. Elahi, M.M.; Kong, Y.X.; Matata, B.M. Oxidative stress as a mediator of cardiovascular disease. Oxid. Med. Cell Longev. 2009, 2, 259-269.
57. Keller, H.; Dreyer, C.; Medin, J.; Mahfoudi, A.; Ozaro, K.; Wahli, W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferatoa-ctivated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 1993, 90, 2160-2164.
58. Narula, J.; Haider, N.; Virmani, R.; DiSalvo, T.GK; olodgie, F.D.; Hajjar, R.J.; Schmidt, U.; Semigran, M.J.; Dec, G.W.; Khav, B.A. Apoptosis in myocytes insta e heart failure. N. Engl. J. Med. 1996, 335, 1182-1189.
59. Langsjoen, P.H.; Langsjoen, A.M. Supplemental ubiquinol in patients with advances congestive heart failure. Biofactors 2008, 32, 119-128.
60. Prior R.L.; Cao G. In vivo total antioxidant capacity:Comparison of different analytical methods. Free Radic. Biol. Med. 1999, 27, 1173-1181.
61. Bartoz, G. Total antioxidant capacity. Adv. Clin. Chem. 2003, 37, 219-292.
62. Chevion, S.; Chevion, M. Antioxidant status and human health. Use of cyclic voltammetry for the evaluation of the antioxidant capacity of plasma and of edible plant. Ann. N. Y. Acad. Sci. 2000, 899, 308-325.
63. Kedziora-Kornatowska, K.; Bartosz, M.; Mussur M.; Zaslonk J., Kedziora J.; Bartosz, G. The total antioxidant capacity of blood plasma during cardiovasculary bypass surgery in patients with coronary heart disease. Cell Mol. Biol. Lett. 2003, 8, 973-977.
64. Mosca, F.; Fattorini, D.; Bompadre, S.; Littarru, G.P. Assay of coenzyme Q(10) in plasma by a single dilution step. Anal. Biochem. 2002, 305, 49-54.
65. Meucci, E.; Milardi, D.; Mordente, A.; Martorana, G.E.; Giaccde Marinis L.; Mancini A. Total antioxidant capacity in patients with varicoce. Feertil. Steril. 2003, 79, 1577-1583.
66. Rice-Evans, C.; Miller, N.J. Total antioxidant status in plasma and body fluids. Methods Enzymol. 1994, 234, 279-293.
67. Mancini, A.; Raimondo, S.; di Segni, C.; Persano, M.; Pontecorvi, A. Non-Thyroidall lness: Physiopathology and Clinical Implications. In Current Topics in Hypothyroidism with Focus on Development; Potlukova, E., Ed.; InTech: Rijeka, Croatia, 2013; pp. 183-202.
68. Rubenfeld, S. Euthyroid sick syndrome. N. Engl. J. Med. 1978, 299, 1414.
69. Wartofsky, L.; Burman, K.D. Alterations in thyroid function in patients with systemic illness: The "Euthyroid sick syndrome". Endocr. Rev. 1982, 3, 164-217.
70. Chopra, I.J. Euthyroid sick syndrome: Abnormalities in circulating thyroid hormones and thyroid hormone physiology in nonthyroid illness (NTI). Med. Grand Rounds 1982, 1, 201-212.
71. Chopra, I.J.; Chopra, U.; Smith, S.R.; Reza. Solomon D.H. Reciprocal changes in serum concentrations of 3,3',5-triiodothyronine (T3) in systemic illnesses. J. Clin. Metab. 1975, 41, 1043-1049.
72. Umpierrez, G.E. Euthyroid sick syndrome. South. Med. J. 2002, 95, 506-513.
73. Michalaki, M.; Vagenakis, A.G.; Makri, M.; Kalfarentzos, F.; Kyriazopoulou, V. Dissociation of the early decline in serum T(3)concentration and serum IL-6 rise and TNF-alpha in nonthyroidal illness syndrome induced by abdominal surge. Jry.Clin. Endocrinol. Metab. 2001, 86, 4198-4205.
74. Chopra J. Clinical review 86: Euthyrosiidc k syndrome: Is it amisnomer? J. Clin. Endocrinol. Metab. 1997, 82, 329-334.
75. Bermudez, F.; Surks, M.I.; Oppenheimer, J.H. High incidence of decreased s triiodothyronine concentration in patients with nonthyroidal disease.J. Clin. Endocrinol. Metab.1975, 41, 27-40.
76. Kaplan, M.M.; Larsen, P.R.; Crantz F., Dzau V.J.; Rossing T.H.; Haddow J.E. Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am. J. Med. 1982, 72, 9-16.
77. Marx, C.; Petros, S.; Bornstein, S.R.; Weise, M.; Wendt, M.; Menschikowski, M.; Engelmann, L.; Hoffken, G. Adrenocortical hormones in survivors and nonsurvivors of severe sepsi Diverse time course of dehydroepiandrosterone, dehydroepiandroster seulfate, and cortisol. Crit. Care Med. 2003, 31, 1382-1388.
78. Schuetz, P.; Muller, B.; Nusbaumer, C.; Wieland, M.; Chrcsrtain, M. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. Eur. J. Endocrinol. 2009, 160, 157-163.
79. Van den Berghe, G.; de Zegher, F.; Bouillon, R. Acute and prolonged critical illness as different neuroendocrine paradigms. J. Clin. Endocrinol. Metab. 1998, 83, 1827-1834.
80. Van den Berghe G. Dynamic neuroendocrine responses to critical. Frontiers Neuroendocrinol. 2002, 23, 370-391.
81. Mancini, A.; Corbo G.M.; Gaballo, A.; Raimondo S.; di Segni C.; Gigliotti P.; Silvestrini A.; Valente S.; Littarru G.P.; Pontecorv A.; et al. Relationships between plasma antioxidants and and thyroid hormones in chronic obstructive pulmonary disease. Exp. Clin. Endocrinol. Diabetes 2012, 120, 623-628.
82. Peeters, R.P.; Wouters, P.J.; Kaptein E.; van Toor H.; Visser T.J.; Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J. Clin. Endocrinol. Metab. 2003, 88, 3202-3211.
83. Luca, F.; Goichot, B.; Brue, T. Non thyroidal illnesses NTIS. Ann. Endocrinol. (Paris) 2010, 71, S13-S24.
84. Economidou, F.; Douka, E.; Tzanela, M.; Nanas, S.; Kotanidou, A. Thyroid function during critical illness. Hormones 2011, 10, 117-124.
85. Bello, G.; Ceaichisciuc, I.; Silva, S.; Antonelli, M. The role of thyroid dysfunction in the critically ill: A review of literature. Minerva Anestesiol. 2010, 76, 919-928.
86. Magagnin Wajner, S.; Maia, A.L. New insights toward the acute non thyroidal illness syndrome. Front. Endocrinol. 2012, 3, 1-7.
87. Cruz, A.; Rodriguez-Gomez, I.; Perez-Abud, R.; Vargas, M.A.; Wagensteen R.; Quesada A.; Osuna A.; Moreno J.M. Effects of clofibrate on salt loainduced hypertension in rats. J. Biomed. Biotechnol. 2011, 469481:1-469481:8.
88. Abilés, J.; dela Cruz, A.P.; Castano, J.; Rodrigu-Elvira, M.; Aguayo, E.; MorenoTorres R.; Llopis, J.; Aranda, P.; Arguelles, S.; Ayala, A.; et al. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independently of severiAy:cohort study. Crit. Care 2006, 10, R146.
89. Hennemann, G.; Docter, R.; Krenning, E.P. Causes and effects of the low T3 syndrome during caloric deprivation and non-thyroidal illness: An overview. Acta Med. Austriaca 1988, 15, 42-45.
90. Monig, H.; Arendt, T.; Meyer, M.; Kloehn, S.; Bewig, B. Activation hypothalamo-pituitary-adrenal axis in response to septic or n septic diseases-implications for the euthyroid sick syndrome. Intensive Care Med. 1999, 25, 1402-1406.
91. Cherem, H.J.; Nellen, H.H.; Barabejski, F.G.; Chong, M.B.A.; Lifshits, G.A. Thyroid function and abdominal surgery. A longitudinal study. Arch. Med. Res. 1992, 23, 143-147.
92. Ilias, I.; Stamoulis, K.; Armaganidis, L., Ayberopoulos, P.; Tzanela M.; Orfanos S.; Theodorakopoulou M.; Tsagarakis S.; Dimopoulou I. Contributionof endocrine parameters in predicting outcome of multiple trauma patients in an intensive careu. Hiormones 2007, 6, 218-226.
93. Vardarli, I.; Schmidt, R.; Wdowinski, J.; Teuber, J.; Schwedes, U.; Usadel. The hypothalamhypophyseal thyroid axis, plasma protein concentration and hypophyseogonadal axis in low T3 syndrome following acute myocardialin. Klin Wochenschr 1987, 65, 129-133.
94. Hamilton, M.A.; Stevenson, L.W.; Lun, M.; Walden, J.A. Altered thyroid hormone metabolism in advanced heart failure. J. Am. Coll. Cardiol. 1990, 16, 91-95.
95. Holland, F.W.; Brown, P.S.; Weintraub, B.D.; Clark, R.E. Cardiopulmonary bypass and thyroid function: an "euthyroid sick syndrome". Ann. Thorac. Surg. 1991, 52, 46-50.
96. Scoscia, E.; Baglioni, S.; Eslami, A.; Iervasi, G.; Monti, S.; Todisco, T. Clinical stud "Low triiodothyronine (T3) state:A predictor of outcome in respiratory failureR esults of a clinical pilot study". Eur. J. Endocrinol. 2004, 151, 557-560.
97. Vexiau, P.; Pere-Castiglioni, P.; Socie, G.; Devergie, A.; Toubert, M.E.; Aractingi, S.; Gluckmann, E. The "Euthyroid sick syndrome"I:ncidence, risk factors and prognostic value soon after allogenic bone marrow transplantation. Br. J. Hematol. 1993, 85, 778-782.
98. Kaptein, E.M. Clinical relevance of thyroid hormone alterations ithyrnooidal illness. Thyroid Int. 1997, 4, 22-25.
99. Wang, F.; Pan, W.; Wang, H.; Wang, S.; Pan Ge, J. Relationship between thyroid function and ICU mortality: A prospective observation study. Crit. Care 2012, 16, R11.
100. Bello, G.; Pennisi, M.A.; Montini, L.; Silva, S.; Maviglia, R.; Cavallaro, F.; Bianchi, A.; de Marinis, L.; Antonelli, No nthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. Chest 2009, 135, 1448-1454.
101. Klein, I.; Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 344, 501-509.
102. Everts, M.E.; Verhoeven, F.A.; Bezstarosti, K.; Moerings, E.P.; Hennemann, G.; Visser, T.J.; Lamers, J.M. Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology 1996, 137, 4235-4242.
103. Dillmann W.H. Biochemical basis of thyroid hormone action in the heart. Am. J. Med. 1990, 88, 626-630.
104. Franklyn, J.A.; Gammage, M.D.; Ramsden, D.B.; Sheppard, M.C. Thyroid status in patients after acute myocardial infarction. Clin. Sci. (Lond.) 1984, 67, 585-590.
105. De Marinis, L.; Mancini, A.; Masala, R.; Torlontano, M.; Sandricino A. Evaluation of pit thyroid axis response to acute myocardial infar. J. Endocrinol. Invest. 1985, 8, 507-511.
106. Opasich, C.; Pacini, F.; Ambrosino, N. Sick euthyroid syndrome in patients with moderate to severe chronic heart failure. Eur. Heart J. 1996, 17, 1860-1866.
107. Iervasi, G.; Pingitore, A.; Landi, P.; Raciti, M.; Ripoli, A.; Scarlattini, M.; L'Abbate, A.; Donato, L. Low T3 syndrome: A strong prognostic predictor of death in patients with heart disease. Circulation 2003, 107, 708-713.
108. Pingitore, A.; Galli, E.; Barison, A.; Iervasi, A.; Scarlattini, M.; Nucci, D.; L'Abbate, A.; Mariotti, R.; Iervasi G. Acute effects of triiothyronine (T3) replacement therapy in patients with chronic heart failure and T 3 syndrome: A randomized, pacebo-controlled study. J. Clin. Endocrinol. Metab. 2008, 93, 1351-1358.
109. Klemperer, J.D.; Klein, I.; Gomez, M.; Helm, R.E.; Ojamaa, K.; Thomas, S.J.; Isom, O.W.; Krieger, K. Thyroid hormone treatment after coronarya-rtery bypass surgery. N. Engl. J. Med. 1995, 333, 1522-1527.
110. Mullis-Jansson, S.L.; Argenziano, M.; Corwin, S.; Homma, S.; Weinberg, A.D.; Williams, M.; Rose, E.A.; Smith, C.R. A randomized doublblind study of the effect of triodothyronine on cardiac function and morbidity after coronary bypass surge. JyThorac. Cardiovasc. Surg. 1999, 117, 1128-1134.
111. Mancini, A.; Corbo, G.M.; Scapigliati, A.; Leone, E.; Conti M., Littarru G.P.; Meucci, E.; de Marinis L.; Pontecorv A. Low-T3 syndrome in chronic obstructive pulmonary disease and heart surgery patients: Evaluation of plasma antioxidant systems. Endocr. Abstr. 2008, 16, 752.
112. De Groot L.J. Dangerous dogmas in medTihene: nonthyroidal illness syndrome. J. Clin. Endocrinol. Metab. 1999, 84, 151-164.
113. Chopra, I.J. Nonthyroidal illness syndrome or euthyroid sick syndrome?. Endocr. Pract. 1996, 2, 45-52.